At 2mg three times weekly, your 100mg vial provides approximately 16-17 weeks of supply, well over the typical 8-12 week cycle length
Low-dose interleukin-2 treatment selectively modulates CD4 + T cell subsets in patients with systemic lupus erythematosus
While it is not FDA-approved for medical use, it has gained popularity in the performance and recovery world for its reported effects on: Tendon and ligament repair Joint pain relief Gut lining protection Muscle recovery and regeneration To learn more about BPC-157s full range of potential benefits and its classification as a research compound, see What Is BPC-157
Zhou H., Li X., Li Y., Zhu X., Zhang L., and Li J., Synthesis and Bioevaluation of 1Phenylimidazole4Carboxylic Acid Derivatives as Novel Xanthine Oxidoreductase Inhibitors, European Journal of Medicinal Chemistry 186 (2020): 111883, 10.1016/j.ejmech.2019.111883